Synthetic Biology

Lord Patel Excerpts

Wednesday 2nd June 2010 Lords Chamber

[Lord Freud]

My Lords, a process will start in September to look at the regulatory controls around this area. During that period, there will be a full consultation leading to changes to the regulations in order to reinforce protections, particularly around artificial cells. If all goes to plan, these should be ready by next April.

[Lord Patel]

My Lords, does the Minister agree that this is not an artificial cell in the true sense because a cytoplasm of the cell came from an organism itself? That aside, systematic biology offers great potential for developments of all kinds. First, what is at stake here is to make sure that this technology is not patented. If it is, it will give a monopoly to a lot of other systematic biology technologies. Secondly, President Obama has already set up a bioethics advisory committee to advise him on the implications of this research. Does the Minister agree that it would be a good idea to do this in our country? Thirdly, if noble Lords attend or take part in next week’s debate on genomic medicine, they might learn even more.

[Lord Freud]

My Lords, I look forward to attending that debate. As the noble Lord has pointed out, the experiment by Professor Craig Venter consisted essentially of taking the DNA from one bacterium, mycoplasma mycoides, modifying it and then putting it inside another bacterium, mycoplasma capricolum. Technically, that is not the creation of an artificial cell, but that is prospectively the next invention that could come along. That is why we need to make sure that the regulations will cover it.

I can inform the noble Lord that Craig Venter’s experiment is being patented, although observations in the scientific press indicate that that does not represent a risk of him subsequently seizing control of the whole of synthetic biology.